Estimates Revisions Myriad Genetics, Inc.
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
23:00:00 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.160 USD | -0.63% |
|
-1.25% | -48.62% |
| 07-31 | Myriad Genetics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Myriad Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Stocks
- MYGN Stock
- Consensus Myriad Genetics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
